Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1050 Results

Intervention Indication Therapeutic Area Year Actions
Vericiguat for chronic heart failure with reduced ejection fraction Vericiguat (BAY1021189; MK-1242) Heart failure (HF) Cardiovascular System 2019 View  |  Download
Vestronidase alfa (UX-003) for mucopolysaccharidosis type VII (MPS 7; Sly syndrome) Vestronidase alfa (Mepsevii; rhGUS; UX003) Mucopolysaccharidosis type VII Endocrine Nutritional and Metabolic Disorders 2017 View  |  Download
Veverimer for metabolic acidosis associated with chronic kidney disease TRC101 (Veverimer) Metabolic acidosis Cardiovascular System , Endocrine Nutritional and Metabolic Disorders , Nephrology 2020 View  |  Download
VF-001 (VitroGro ECM) for venous leg ulcer VF-001 (VitroGro ECM) Venous leg ulcers Cardiovascular System , Dermatology 2017 View  |  Download
Viaskin Peanut – peanut allergy immunotherapy (DBV 712; EPIT Peanut) for paediatric patients aged 4-11 DBV-712 (Viaskin peanut) Peanut allergy Immunology 2017 View  |  Download
Vibegron for treating overactive bladder Vibegron (MK-418; Gemtesa; Beova) Overactive bladder Urology 2023 View  |  Download
Voclosporin for lupus nephritis Voclosporin (ISA247) Lupus nephritis Immunology , Nephrology 2021 View  |  Download
Volixibat for non-alcoholic steatohepatitis (NASH) Volixibat (SHP626; LUM-002) Non-alcoholic steatohepatitis (NASH) Hepatology 2017 View  |  Download
Vonicog alfa for Prophylaxis of Haemorrhage in Von Willebrand disease Vonicog alfa (recombinant von Willebrand factor) von Willebrand disease Genetic Disorders , Haematology 2023 View  |  Download
Vosoritide for achondroplasia Vosoritide (BMN 111) Achondroplasia Musculoskeletal System 2020 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications